Max Guarda, MD
@max_guarda
Internal Medicine PGY1 @thaaIMres | Research Collaborator @mayoclinic | 🇨🇱 & 🇺🇸 | IMG @UDD_FM | Views are my own
ID: 1562877791590240258
https://orcid.org/0009-0005-9163-0781 25-08-2022 19:01:23
382 Tweet
978 Followers
1,1K Following
It was great meeting Baptiste Chevet at #EULAR2024 who also presented a great study on #Tocilizumab discontinuation in patients with Polymyalgia Rheumatica: ➡️ High rate of #PMR relapse when TCZ is abruptly discontinued!
📢📢Applications are open for a research fellow/study coordinator position at Rush Rheumatology to join the Myositis Research Team. Please send an email to [email protected] with your CV. IMGs and those with prior clinical research experience are encouraged to apply.
Max Guarda, MD I 💯 support day off treats
Sharing our latest work with KenWarringtonMD in Annals of the Rheumatic Diseases! We used SomaLogic proteomics to identify blood protein patterns in active and inactive Giant Cell Arteritis. Sights are now set to develop and validate ML-based multiplex biomarker panels for GCA!🚀 ard.bmj.com/content/early/…
Membranous nephropathy (MN) can occur in the transplant kidney as recurrent or de novo MN. Recurrent MN is often PLA2R+ De novo MN is PLA2R-negative & often associated with antibody-mediated rejection. The target antigen is unknown FAT1 is the antigen! kidney-international.org/article/S0085-…
Comprehensive review of Intermediate-Risk #PE led by Nichole Brunton, DO with Mayo Clinic CV MayoPCCM teamwork! Our proposed algorithm for management below. PERT Consortium Society for Vascular Medicine | SVM American College of Cardiology AHA Peripheral Vascular Disease Council
Why I love working at Mayo Clinic: 10 AM – Incidental PE on CT, asymptomatic. 11 AM – Labs done. 12 PM – Patient gets lunch. 1 PM – Thrombophilia clinic, Lovenox shot. 2 PM – Rheum clinic with me. 3 PM – DOAC ready at Mayo Pharmacy. Seamless, coordinated care at its best!